(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LGALSL mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LGALSL mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of LGALSL mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO LGALSL (Homo sapiens) 6480464 Estradiol results in increased expression of LGALSL mRNA CTD PMID:31614463 17beta-estradiol decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Estradiol results in decreased expression of LGALSL mRNA CTD PMID:35192832 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO LGALSL (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALSL mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALSL mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LGALSL mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lgalsl (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALSL mRNA CTD PMID:21215274 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgalsl (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALSL mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LGALSL mRNA] CTD PMID:21215274 2-hydroxypropanoic acid decreases expression ISO LGALSL (Homo sapiens) 6480464 Lactic Acid results in decreased expression of LGALSL mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of LGALSL mRNA CTD PMID:25380136 acrolein multiple interactions ISO LGALSL (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LGALSL mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LGALSL mRNA CTD PMID:32699268 Actein decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 actein results in decreased expression of LGALSL protein CTD PMID:29969672 all-trans-retinoic acid decreases expression ISO LGALSL (Homo sapiens) 6480464 Tretinoin results in decreased expression of LGALSL mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO LGALSL (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LGALSL mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LGALSL mRNA CTD PMID:32699268 antirheumatic drug increases expression ISO LGALSL (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of LGALSL mRNA CTD PMID:24449571 arsane multiple interactions ISO LGALSL (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LGALSL mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO LGALSL (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LGALSL mRNA CTD PMID:32525701 arsenous acid multiple interactions ISO LGALSL (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LGALSL protein] CTD PMID:26598702 azoxystrobin multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO Lgalsl (Rattus norvegicus) 6480464 Benzo(a)pyrene results in increased expression of LGALSL mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I increases expression ISO LGALSL (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of LGALSL mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide increases expression ISO LGALSL (Homo sapiens) 6480464 Mustard Gas results in increased expression of LGALSL mRNA CTD PMID:25102026 bisphenol A increases expression ISO Lgalsl (Rattus norvegicus) 6480464 bisphenol A results in increased expression of LGALSL mRNA CTD PMID:25181051 more ... buspirone decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Buspirone results in decreased expression of LGALSL mRNA CTD PMID:24136188 caffeine decreases phosphorylation ISO LGALSL (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of LGALSL protein CTD PMID:35688186 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 CGP 52608 multiple interactions ISO LGALSL (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to LGALSL gene] CTD PMID:28238834 chlorpyrifos multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA CTD PMID:33854195 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of LGALSL mRNA CTD PMID:37019170 clobetasol increases expression EXP 6480464 Clobetasol results in increased expression of LGALSL mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of LGALSL mRNA CTD PMID:24386269 copper atom increases expression ISO Lgalsl (Rattus norvegicus) 6480464 Copper results in increased expression of LGALSL mRNA CTD PMID:30556269 copper(0) increases expression ISO Lgalsl (Rattus norvegicus) 6480464 Copper results in increased expression of LGALSL mRNA CTD PMID:30556269 coumarin increases phosphorylation ISO LGALSL (Homo sapiens) 6480464 coumarin results in increased phosphorylation of LGALSL protein CTD PMID:35688186 cyclosporin A increases methylation ISO LGALSL (Homo sapiens) 6480464 Cyclosporine results in increased methylation of LGALSL promoter CTD PMID:27989131 decabromodiphenyl ether decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of LGALSL mRNA CTD PMID:23640034 diarsenic trioxide multiple interactions ISO LGALSL (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LGALSL protein] CTD PMID:26598702 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 diquat increases expression EXP 6480464 Diquat results in increased expression of LGALSL protein CTD PMID:36851058 doxorubicin decreases expression ISO LGALSL (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LGALSL mRNA CTD PMID:29803840 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of LGALSL mRNA CTD PMID:35436446 ethanol affects expression EXP 6480464 Ethanol affects the expression of LGALSL mRNA CTD PMID:30319688 flutamide decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Flutamide results in decreased expression of LGALSL mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LGALSL mRNA CTD PMID:22206623 gentamycin decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of LGALSL mRNA CTD PMID:33387578 glyphosate multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA CTD PMID:33854195 hydroquinone increases expression ISO LGALSL (Homo sapiens) 6480464 hydroquinone results in increased expression of LGALSL mRNA CTD PMID:31256213 imidacloprid multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA CTD PMID:33854195 indole-3-methanol multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA CTD PMID:22129741 ivermectin decreases expression ISO LGALSL (Homo sapiens) 6480464 Ivermectin results in decreased expression of LGALSL protein CTD PMID:32959892 methapyrilene decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of LGALSL mRNA CTD PMID:30467583 N-acetyl-L-cysteine multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA CTD PMID:22129741 N-nitrosodimethylamine decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Dimethylnitrosamine results in decreased expression of LGALSL mRNA CTD PMID:25380136 nefazodone decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 nefazodone results in decreased expression of LGALSL mRNA CTD PMID:24136188 nimesulide decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 nimesulide results in decreased expression of LGALSL mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LGALSL mRNA CTD PMID:25729387 ozone multiple interactions ISO LGALSL (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LGALSL mRNA more ... CTD PMID:32699268 p-toluidine decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 4-toluidine results in decreased expression of LGALSL mRNA CTD PMID:27638505 paracetamol increases expression ISO LGALSL (Homo sapiens) 6480464 Acetaminophen results in increased expression of LGALSL mRNA CTD PMID:22230336 paracetamol decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of LGALSL mRNA CTD PMID:33387578 paracetamol decreases expression ISO LGALSL (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LGALSL mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of LGALSL protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LGALSL mRNA CTD PMID:36331819 phenobarbital affects expression ISO LGALSL (Homo sapiens) 6480464 Phenobarbital affects the expression of LGALSL mRNA CTD PMID:19159669 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of LGALSL mRNA CTD PMID:23091169 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of LGALSL mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of LGALSL mRNA CTD PMID:28903501 progesterone decreases expression ISO LGALSL (Homo sapiens) 6480464 Progesterone results in decreased expression of LGALSL mRNA CTD PMID:20864642 rac-lactic acid decreases expression ISO LGALSL (Homo sapiens) 6480464 Lactic Acid results in decreased expression of LGALSL mRNA CTD PMID:30851411 rotenone decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 Rotenone results in decreased expression of LGALSL mRNA CTD PMID:28374803 rotenone decreases expression ISO LGALSL (Homo sapiens) 6480464 Rotenone results in decreased expression of LGALSL mRNA CTD PMID:29955902 sodium arsenate multiple interactions ISO LGALSL (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LGALSL mRNA CTD PMID:32525701 sodium arsenite increases expression ISO LGALSL (Homo sapiens) 6480464 sodium arsenite results in increased expression of LGALSL mRNA CTD PMID:22714537 sodium arsenite affects expression ISO LGALSL (Homo sapiens) 6480464 sodium arsenite affects the expression of LGALSL mRNA CTD PMID:29319823 sunitinib increases expression ISO LGALSL (Homo sapiens) 6480464 Sunitinib results in increased expression of LGALSL mRNA CTD PMID:31533062 temozolomide increases expression ISO LGALSL (Homo sapiens) 6480464 Temozolomide results in increased expression of LGALSL mRNA CTD PMID:31758290 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LGALSL mRNA CTD PMID:27339419 thiabendazole multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA CTD PMID:33854195 thimerosal decreases expression ISO LGALSL (Homo sapiens) 6480464 Thimerosal results in decreased expression of LGALSL mRNA CTD PMID:27188386 thioacetamide increases expression ISO Lgalsl (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of LGALSL mRNA CTD PMID:34492290 topotecan multiple interactions ISO Lgalsl (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LGALSL mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of LGALSL mRNA CTD PMID:25549359 triphenyl phosphate decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of LGALSL mRNA CTD PMID:30589522 trovafloxacin decreases expression ISO Lgalsl (Rattus norvegicus) 6480464 trovafloxacin results in decreased expression of LGALSL mRNA CTD PMID:24136188 urethane decreases expression ISO LGALSL (Homo sapiens) 6480464 Urethane results in decreased expression of LGALSL mRNA CTD PMID:28818685 valproic acid decreases expression ISO LGALSL (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LGALSL mRNA CTD PMID:23179753 valproic acid affects expression ISO LGALSL (Homo sapiens) 6480464 Valproic Acid affects the expression of LGALSL mRNA CTD PMID:25979313 vinclozolin affects expression ISO Lgalsl (Rattus norvegicus) 6480464 vinclozolin affects the expression of LGALSL mRNA CTD PMID:19015723